European Archives - Page 553 of 1053 - European Medical Journal

EMJ Oncology 8.1 2020 Feature Image

The Importance of Molecular Testing in the Treatment of Cholangiocarcinoma

Cholangiocarcinomas (CCA) belong to the constellation of biliary tract cancers (BTC), along with gallbladder carcinomas and ampullary carcinomas…

PEAR Study: UK Experience of the Management of Pregnancy-Associated brEast cAnceR: A National Retrospective Review of Practice

Breast cancer is the leading cause of death in females aged 35–54 years and 15% of breast cancers first present in females of reproductive age…

race against time

Breast cancer (BC), which is the most prevalent malignancy in women worldwide, is a heterogeneous disease, in which human epidermal growth…

Association of Tumour Location and Recurrence in Patients with Non-Muscle Invasive Bladder Cancer

Risk stratification and prognosis estimation is important in patients with non-muscle invasive bladder cancer (NMIBC). NMIBC has a high probability…

Chemotherapy Options in Recurrent Glioblastoma

Most patients with glioblastoma will develop a recurrence despite initial aggressive therapy with maximum surgical resection and postoperative chemoradiation…

Phosphate and Oxysterols May Mediate an Inverse Relationship Between Atherosclerosis and Cancer

“If it’s not one thing, it’s another” is the sardonic title of an article by Li et al.1 which describes a puzzling inverse relationship between cancer…

Nasopharyngeal Rhabdomyosarcoma: A Rare Malignancy Incidentally Found in a Middle-Aged Male with a Diagnostic Dilemma

Rhabdomyosarcoma (RMS) is an infrequent and aggressive malignancy that emerges from embryonic mesenchymal cells…

Are We Virtually There Yet? Part 1 of 2

This two-part webinar features experts who have been on the leading edge of technology in medicine and share their thoughts on where telemedicine was, where it is now and where it is going.

EMJ Neurology 8 [Supplement 1] 2020 Feature Image

EMJ Neurology 8 [Supplement 1] 2020

Currently, 50 million people are living with Alzheimer’s disease (AD), with estimates suggesting an increase to >150 million by 2050…

Empowering Physicians to Advance the Future of Alzheimer’s Disease Management and Care

This series of four talks was aimed at providing healthcare professionals (HCP) with an understanding of the need for early diagnosis of AD to enable refined care